A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer
Clinical trial NCT05132413 · UNKNOWN
Trial details
- NCT number
- NCT05132413
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2024-12-30
- Enrollment
- 561
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.